An ENU-induced mutation in AP-2α leads to middle ear and ocular defects in Doarad mice

被引:19
作者
Ahituv, N
Erven, A
Fuchs, H
Guy, K
Ashery-Padan, R
Williams, T
de Angelis, MH
Avraham, KB [1 ]
Steel, KP
机构
[1] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel
[2] MRC, Inst Hearing Res, Nottingham, England
[3] GSF, Res Ctr Environm & Hlth, Inst Expt Genet, Neuherberg, Germany
[4] Univ Colorado, Hlth Sci Ctr, Dept Craniofacial Biol, Denver, CO USA
[5] Univ Colorado, Hlth Sci Ctr, Dept Cell & Struct Biol, Denver, CO USA
关键词
D O I
10.1007/s00335-004-2334-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
One of the advantages of N-ethyl- N-nitrosourea (ENU)-induced mutagenesis is that, after randomly causing point mutations, a variety of alleles can be generated in genes leading to diverse phenotypes. For example, transcription factor AP-2alpha (Tcfap2a) null homozygote mice show a large spectrum of developmental defects, among them missing middle car bones and tympanic ring. This is the usual occurrence, where mutations causing middle ear anomalies usually coincide with other abnormalities. Using ENU-induced mutagenesis, we discovered a new dominant Tcfap2a mutant named Doarad (Dor) that has a missense mutation in the PY motif of its transactivation domain, leading to a misshapen malleus, incus, and stapes without any other observable phenotype. Dor homozygous mice die perinatally, showing prominent abnormal facial structures and ocular defects. In vitro assays suggest that this mutation causes a "gain of function" in the transcriptional activation of AP-2alpha. These mice enable us to address more specifically the developmental role of Tcfap2a in the eye and middle ear and are the first report of a mutation in a gene specifically causing middle ear abnormalities, leading to conductive hearing loss.
引用
收藏
页码:424 / 432
页数:9
相关论文
共 35 条
[1]   Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye [J].
Ashery-Padan, R ;
Marquardt, T ;
Zhou, XL ;
Gruss, P .
GENES & DEVELOPMENT, 2000, 14 (21) :2701-2711
[2]   Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator [J].
Bamforth, SD ;
Bragança, J ;
Eloranta, JJ ;
Murdoch, JN ;
Marques, FIR ;
Kranc, KR ;
Farza, H ;
Henderson, DJ ;
Hurst, HC ;
Bhattacharya, S .
NATURE GENETICS, 2001, 29 (04) :469-474
[3]  
Bosher JM, 1996, ONCOGENE, V13, P1701
[4]   Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2 [J].
Bragança, J ;
Swingler, T ;
Marques, FIR ;
Jones, T ;
Eloranta, JJ ;
Hurst, HC ;
Shioda, T ;
Bhattacharya, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) :8559-8565
[5]   HEARING IN CHRONIC SUPPURATIVE OTITIS-MEDIA [J].
BROWNING, GG ;
GATEHOUSE, S .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1989, 98 (04) :245-250
[6]   THE WW DOMAIN OF YES-ASSOCIATED PROTEIN BINDS A PROLINE-RICH LIGAND THAT DIFFERS FROM THE CONSENSUS ESTABLISHED FOR SRC HOMOLOGY 3-BINDING MODULES [J].
CHEN, HI ;
SUDOL, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7819-7823
[7]   Genome-wide, large-scale production of mutant mice by ENU mutagenesis [J].
de Angelis, MH ;
Flaswinkel, H ;
Fuchs, H ;
Rathkolb, B ;
Soewarto, D ;
Marschall, S ;
Heffner, S ;
Pargent, W ;
Wuensch, K ;
Jung, M ;
Reis, A ;
Richter, T ;
Alessandrini, F ;
Jakob, T ;
Fuchs, E ;
Kolb, H ;
Kremmer, E ;
Schaeble, K ;
Rollinski, B ;
Roscher, A ;
Peters, C ;
Meitinger, T ;
Strom, T ;
Steckler, T ;
Holsboer, F ;
Klopstock, T ;
Gekeler, F ;
Schindewolf, C ;
Jung, T ;
Avraham, K ;
Behrendt, H ;
Ring, J ;
Zimmer, A ;
Schughart, K ;
Pfeffer, K ;
Wolf, E ;
Balling, R .
NATURE GENETICS, 2000, 25 (04) :444-447
[8]  
DECLAU F, 1996, GENETICS HEARING IMP, P221
[9]  
EVANS EF, 1975, AUDIOLOGY, V14, P419
[10]  
Hermanns P, 2001, AM J MED GENET, V106, P258, DOI 10.1002/ajmg.10231